Approval · Notice of Compliance 12824 · 2011
FINASTERIDE: Notice of Compliance 12824
Issued December 1, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12824
- Date
- December 1, 2011
- Company
- Frosst A Division Of Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New Manufacturer and Product Name
- Therapeutic class
- Type II 5 Alpha-reductase Inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FINASTERIDE | 02375303 | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB